Monitoring medicines use: The role of the clinical pharmacologist

British Journal of Clinical Pharmacology

Volumn 74, Issue 4, 2012, Pages 685-690

  Williams, David ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Drug utilization; Medication error; Patient safety; Pharmacoepidemiology; Pharmacovigilence

Indexed keywords

HEPARIN; INSULIN; NARCOTIC AGENT; POTASSIUM CHLORIDE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL PHARMACOLOGY; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG UTILIZATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LICENCE; MEDICAL ERROR; PATIENT SAFETY; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG MONITORING; DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PHARMACOEPIDEMIOLOGY; PHARMACOLOGY, CLINICAL; PHARMACOVIGILANCE; PRODUCT SURVEILLANCE, POSTMARKETING; PROFESSIONAL ROLE;

EID: 84865841672     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04316.x     Document Type: Article

References (43)

1. Osler W. Recent advances in medicine. Science 1891; 17: 170-1.
2. Aronson J. A manifesto for clinical pharmacology from principles to practice. Br J Clin Pharmacol 2010; 70: 3-13.
3. Orme M, Sjoqvist F, Birkett D, Brosen K, Cascorbi I, Gustafsson L, Maxwell S, Rago L, Rawlins M, Reidenburg M, Smith T, Thuerman P, Walubo A. Clinical pharmacology in research, teaching and health care. Considerations by IUPHAR, the international union of basic and clinical pharmacology. Basic Clin Pharmacol Toxicol 2010; 107: 531-629.
4. Lawson D. Pharmacoepidemiology: a new discipline. Br Med J 1984; 289: 940-1.
5. WHO. The Use of Essential Drugs: 9th Report of the WHO Expert Committee 1977. Geneva: World Health Organization, 2000.
6. ICH Expert working group. International conference on harmonisation of technical requirements for Registration of pharmaceuticals for human use. ICH harmonised tripartite guideline: pharmacovigilence planning E2E. 2004.
7. European Medicines Agency. Annual report of the European medicines agency, 2008. 2008. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Annual_report/2009/12/WC500016589.pdf (last accessed 5 March 2012).
8. Drugs@FDA. FDA approved products. 2011 Available at http://www.fda.gov/default.htm Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.ReportsMenu (last accessed 5 March 2012).
9. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; 278: 1358.
10. Williams D, Singh M, Hind C. The effect of the withdrawal of rofecoxhib on prescribing patterns of COX-2 inhibitors in Scotland. Br J Clin Pharmacol 2006; 62: 366-8.
11. Chaudhuri A. Lessons for clinical trials from natalizimab in multiple sclerosis. BMJ 2006; 332: 416-9.
12. Pirmohamad M, James S, Meakin S, Green C, Scott A, Walley T, Farrar K, Park B, Breckenridge A. Adverse drug reactions as cause of admission to hospital:prospective analysis of 18820 patients. Br Med J 2004; 329: 15-9.
13. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439. Epub 2009 Feb 11.
14. Pirmohamed M, Breckenridge A, Kitteringham N, Park B. Fortnightly review. Adverse Drug reactions. Br Med J 1998; 316: 1295-8.
15. Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish Doctors. Ir J Med Sci 1999; 168: 257-61.
16. Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J 2011; 312: 1215-8.
17. Stricker B, Psaty B. Detection, verification, and quantification of adverse drug reactions. Br Med J 2004; 329: 44-7.
18. Aagaard L, Soendergaard B, Stenver DI, Hansen EH. Knowledge creation about ADRs-turning the perspective from the rear mirror to the projector? Br J Clin Pharmacol 2008; 65: 364-76.
19. Food and Drug Administration. The sentinel initiative. 2010. Available at http://www.fda.gov/downloads/Safety/FDAsSentinelInitiative/UCM233360.pdf (last accessed 5 March 2012).
20. European Commission. EU-ADR Project ('Exploring and Understanding adverse drug Reactions by integrative mining of clinical records and biomedical knowledge'). European Commission. 2008. Available at http://www.euadr-project.org (last accessed 5 March 2012).
21. Coloma P, Schuemie M, Trifiro G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboon M, on behalf of the EU-ADR consortium. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011; 20: 1-11.
22. European Surveillance of Antimicrobial Consumption. ESAC. 2012. Available at http://app.esac.ua.ac.be/public/ (last accessed 5 March 2012).
23. Medication Error Definition. National Coordinating Council for Medication Error Reporting and Prevention. 2011. Available at http://www.nccmerp.org/aboutMedErrors.html (last accessed 5 March 2012).
24. Barber N, Rawlins M, Dean Franklin B. Reducing prescribing error: competence, control, and culture. Qual Saf Health Care 2003; 12: 29i-32.
25. National Audit Office. A Safer Place for Patients: Learning to Improve Patient Safety. London: National Audit Office, 2005.
26. Ferner RE, Aronson J. Clarification of terminology in medication errors. Definitions and classification. Drug Saf 2006; 29: 1011-22.
27. Williams D. Medication errors. J R Coll Physicians Edinb 2007; 34: 343-6.
28. Reason J. Human Error. Cambridge: Cambridge University Press, 1990.
29. Hope J. Catalogue of errors led to jab death. 2011. Mail on Line. Available at http://www.dailymail.co.uk/news/article-39869/Catalogue-errors-led-jab-death.html (last accessed 5 March 2012).
30. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002; 359: 1373-8.
31. Dornan T, Ashcroft D, Heathfield H, Lewis P, Miles J, Taylor D, Tully M, Wass V. An in Depth Investigation into Causes of Prescribing Errors by Foundation Trainees in Relation to Their Medical Education. EQUIP Study. London: General Medical Council, 2009.
32. All Wales Prescription Chart. All Wales Medicine Strategy Group. 2011. Available at http://www.wales.nhs.uk/sites3/page.cfm?orgid=371&pid=47669 (last accessed 5 March 2012).
33. Sari AB-A, Sheldon TA, Cracknell A, Turnbull A. Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review. Br Med J 2007; 334: 79.
34. Delbanco T, Bell SK. Guilty, afraid, and alone, struggling with medical error. NEJM 2007; 357: 1682-3.
35. Hudson P. Applying the lessons of high risk industries to healthcare. Qual Saf Health Care 2003; 12: i17-i21.
36. Bates DW. Using information technology to reduce rates of medication errors in hospitals. Br Med J 2000; 320: 788-91.
37. Bates DW, Leape L, Cullen D, Laird N, Peterson L, Teich J, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger D. Effect of computerised physician order entry and a team intervention prevention serious medication errors. J Am Med Assoc 1998; 280: 1311-6.
38. Bates DW, Gawande AA. Improving safety with information technology. NEJM 2003; 348: 2526.
39. Cohen M, Kimmel M, Benage M, Cox M, Sanders N, Spence D, Chen J. Medication safety program reduces adverse drug events in the community hospital. Qual Saf Health Care 2005; 14: 169-74.
40. Heaton A, Webb DJ, Maxwell SM. Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol 2008; 66: 128-34.
41. Vollebregt JA, Metz JCM, De Haan M, Richir MC, Hugtenburg JG, De Vries TPGM. Curriculum development in pharmacotherapy: testing the ability of preclinical medical students to learn therapeutic problem solving in a randomized controlled trial. Br J Clin Pharmacol 2006; 61: 345-51.
42. British Pharmacological Society. Prescribe-E-Learning for Clinical Pharmacology and Prescribing. London: British Pharmacological Society, 2011.
43. Maxwell S, Webb D. Clinical pharmacology-too young to die? Lancet 2006; 367: 799-80.